Bioatla Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.09

-0.36 (-10.43%)

As of Aug 14, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +204.2% upside

Low Target $5.45

Average Target $9.40

High Target $11.97

Current Price $3.09

Current
$3.09

Target
$9.40

$5.45 $9.40 avg $11.97

Scenario Analysis

Bear Case

$5.45

76.4%

Low target

Base Case

$9.40

+204.2%

Avg target

Bull Case

$11.97

+287.4%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$71.50

-95.7% from high

52-Week Low

$3.12

+-1.0% from low

Target vs 52W High

$9.40

-86.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%